AWARD
Q -- Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants
- Notice Date
- 10/1/2021 5:29:59 AM
- Notice Type
- Award Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50121P00054
- Archive Date
- 10/05/2021
- Point of Contact
- Jeffrey Schmidt, Phone: 2022050260
- E-Mail Address
-
jeffrey.schmidt2@hhs.gov
(jeffrey.schmidt2@hhs.gov)
- Award Number
- 75A50121P00054
- Award Date
- 09/20/2021
- Awardee
- Monogram Biosciences, Inc. CA 94080-1913 USA
- Award Amount
- 10487400.00
- Description
- The Contractor will provide laboratory assay testing capacity for evaluation of medical countermeasures for SARS-CoV-2 in a pseudovirus neutralization assay (PsVNA). The assay permits analysis of serum samples collected from human subjects (convalescent and/or vaccinated) as well as therapeutic monoclonal and polyclonal antibodies. Samples are to be tested to ascertain the ability to recognize and maintain neutralization versus both predominant circulating and emerging variants of SARS-CoV-2. The current effort seeks to utilize a pseudotyped VN assay for rapid testing of emerging virus variants and expanded medical countermeasures (MCMs).
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/e96d690cb2704d0d889bba436fc1b423/view)
- Record
- SN06149222-F 20211003/211001230112 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |